<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="92394">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01884454</url>
  </required_header>
  <id_info>
    <org_study_id>PSAR01</org_study_id>
    <nct_id>NCT01884454</nct_id>
  </id_info>
  <brief_title>SLEEP AND OSA ON REPRODUCTIVE FUNCTION IN MEN</brief_title>
  <acronym>PSAR01</acronym>
  <official_title>EFFECTS OF SLEEP LOSS AND OBSTRUCTIVE SLEEP APNEA SYNDROME ON REPRODUCTIVE FUNCTION IN MEN</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Federal University of São Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Federal University of São Paulo</source>
  <oversight_info>
    <authority>Brazil: Ethics Committee</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In view of the hormonal changes induced by both sleep deprivation and obstructive sleep
      apnea syndrome (OSA), and the importance of maintaining these hormones in reproductive
      processes. The present study aims to evaluate the effects of the OSA or sleep deprivation
      (total or selective REM sleep for 48h) on reproductive function in adult men with normal
      body mass index.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this study will be recruited volunteers 25-50 years of age with a body mass index (BMI)
      20-25 kg/m2 (normal) that after performing polysomnography, will be distributed in the
      following groups: healthy or diagnosed with obstructive sleep apnea syndrome (OSA).
      Volunteers without OSA will be submitted to total sleep deprivation (SD) or selective REM
      sleep deprivation for 48 hours. After SD, these volunteers will be allowed to sleep for 48
      hours (period rebound). Blood samples will be taken for hormonal analysis (testosterone,
      luteinizing hormone, follicle-stimulating hormone, progesterone and cortisol)and gene
      expression. The semen collection for evaluation of sperm count (concentration, viability and
      sperm morphology) in three different periods, baseline collection, after SD protocols and
      the end of rebound period. Individuals diagnosed with OSA also have three collections of
      blood and semen samples for analyzes.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2013</start_date>
  <completion_date type="Anticipated">September 2014</completion_date>
  <primary_completion_date type="Anticipated">November 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Health Services Research</study_design>
  <primary_outcome>
    <measure>Change in sperm analysis</measure>
    <time_frame>change from baseline, sleep deprivations and rebound period. Participants will be followed for the duration of laboratory stay, an expected average of 7 days</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>- Semen collection (concentration, viability and sperm morphology)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>change hormonal evaluation</measure>
    <time_frame>change from baseline, sleep deprivations and rebound period. Participants will be followed for the duration of laboratory stay, an expected average of 7 days</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>- Hormonal analysis (testosterone, luteinizing hormone, follicle-stimulating hormone, progesterone and cortisol)</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Sleep patterns of the study population</measure>
    <time_frame>Change from baseline, sleep deprivations and rebound period. Participants will be followed for the duration of laboratory stay, an expected average of 7 days</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>- Polysomnography</description>
  </other_outcome>
  <other_outcome>
    <measure>Change gene expression</measure>
    <time_frame>Change from baseline, sleep deprivations and rebound period. Participants will be followed for the duration of laboratory stay, an expected average of 7 days</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Blood will be collected in  specific tubes (PaxGene)for RNA extraction and gene expression determination.</description>
  </other_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Obstructive Sleep Apnea</condition>
  <arm_group>
    <arm_group_label>Total sleep deprivation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Healthy volunteers will be submitted to total sleep deprivation (TSD) for 48 hours.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>moderate to severe OSA</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients diagnosed with moderate to severe obstructive sleep apnea syndrome (OSA) with normal or overweight body mass index (BMI), will be recruited.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>REM sleep deprivation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Healthy volunteers will be submitted to selective REM sleep deprivation (REMSD) for 48 hours.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>The control group will be subjects with an apnea hypopnea index &lt;5/h.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Sleep deprivation</intervention_name>
    <description>Volunteers will be submitted to total sleep deprivation (SD) or selective REM sleep deprivation for 48 hours. After SD, these volunteers will be allowed to sleep for 48 hours (period rebound).</description>
    <arm_group_label>Total sleep deprivation</arm_group_label>
    <arm_group_label>REM sleep deprivation</arm_group_label>
    <other_name>Total sleep deprivation</other_name>
    <other_name>REM sleep deprivation</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  men

          -  There is no discrimination of economic class

          -  Age between 25 and 50

          -  BMI 30 kg/m2

          -  No prior neurological, psychiatric or use of psychotropic medication

          -  OSA (moderate and severe apnea hypopnea index &gt; 15)

        Exclusion Criteria:

          -  smokers

          -  addiction

          -  Individuals with another sleep disorder

          -  Severe uncontrolled organic disease that might interfere with the conduct of the
             study, such as cancer, heart disease, digestive disorders, diabetes mellitus, male
             reproductive system

          -  Presence of moderate or severe depression and psychiatric disorders

          -  Volunteers with previous treatment for OSA
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tathiana A Alvarenga, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Federal University of São Paulo</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Monica L Andersen, Prof</last_name>
    <role>Study Director</role>
    <affiliation>Federal University of São Paulo</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Monica L Andersen, Prof</last_name>
    <phone>55 11 21490155</phone>
    <phone_ext>160</phone_ext>
    <email>ml.andersen12@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Tathiana A Alvarenga, PhD</last_name>
    <phone>55 11 21490155</phone>
    <phone_ext>160</phone_ext>
    <email>tafalvarenga@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Universidade Federal de Sao Paulo</name>
      <address>
        <city>Sao Paulo</city>
        <zip>04024002</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tathiana A Alvarenga, PhD</last_name>
      <phone>55 11 21490155</phone>
      <phone_ext>160</phone_ext>
      <email>tafalvarenga@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Monica L Andersen, Prof</last_name>
      <phone>55 11 21490155</phone>
      <phone_ext>160</phone_ext>
      <email>ml.andersen12@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Tathiana A Alvarenga, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <link>
    <url>http://www.aasmnet.org/</url>
    <description>American Academy of Sleep Medicine</description>
  </link>
  <verification_date>June 2013</verification_date>
  <lastchanged_date>June 20, 2013</lastchanged_date>
  <firstreceived_date>June 18, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Federal University of São Paulo</investigator_affiliation>
    <investigator_full_name>Monica Levy Andersen</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>sleep</keyword>
  <keyword>obstructive sleep apnea</keyword>
  <keyword>reproduction</keyword>
  <keyword>sperm</keyword>
  <keyword>hormones</keyword>
  <keyword>men</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
